Parallel Advisors’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $313K | Buy |
6,503
+1,944
| +43% | +$90.6K | 0.01% | 926 |
|
|
2025
Q4 | $221K | Sell |
4,559
-935
| -17% | -$46.3K | ﹤0.01% | 1054 |
|
|
2025
Q3 | $259K | Sell |
5,494
-1,987
| -27% | -$95.9K | ﹤0.01% | 937 |
|
|
2025
Q2 | $361K | Sell |
7,481
-2,136
| -22% | -$109K | 0.01% | 754 |
|
|
2025
Q1 | $533K | Buy |
9,617
+2,192
| +30% | +$119K | 0.01% | 567 |
|
|
2024
Q4 | $358K | Sell |
7,425
-1,326
| -15% | -$67.4K | 0.01% | 691 |
|
|
2024
Q3 | $504K | Buy |
8,751
+1,019
| +13% | +$55K | 0.01% | 564 |
|
|
2024
Q2 | $375K | Buy |
7,732
+987
| +15% | +$47.6K | 0.01% | 627 |
|
|
2024
Q1 | $328K | Buy |
6,745
+1,214
| +22% | +$59.3K | 0.01% | 674 |
|
|
2023
Q4 | $275K | Sell |
5,531
-1,009
| -15% | -$49.3K | 0.01% | 677 |
|
|
2023
Q3 | $351K | Buy |
6,540
+908
| +16% | +$48.4K | 0.01% | 570 |
|
|
2023
Q2 | $304K | Buy |
5,632
+446
| +9% | +$24K | 0.01% | 622 |
|
|
2023
Q1 | $282K | Buy |
5,186
+825
| +19% | +$40.1K | 0.01% | 629 |
|
|
2022
Q4 | $211K | Sell |
4,361
-1,932
| -31% | -$84.8K | 0.01% | 675 |
|
|
2022
Q3 | $239K | Sell |
6,293
-2,765
| -31% | -$123K | 0.01% | 611 |
|
|
2022
Q2 | $453K | Buy |
9,058
+499
| +6% | +$26.5K | 0.02% | 427 |
|
|
2022
Q1 | $442K | Buy |
8,559
+104
| +1% | +$5.37K | 0.02% | 460 |
|
|
2021
Q4 | $424K | Buy |
8,455
+261
| +3% | +$12.9K | 0.02% | 493 |
|
|
2021
Q3 | $395K | Buy |
8,194
+186
| +2% | +$9.46K | 0.02% | 471 |
|
|
2021
Q2 | $422K | Buy |
8,008
+472
| +6% | +$24.6K | 0.02% | 435 |
|
|
2021
Q1 | $373K | Sell |
7,536
-11
| -0.1% | -$528 | 0.02% | 435 |
|
|
2020
Q4 | $367K | Sell |
7,547
-379
| -5% | -$18.7K | 0.02% | 394 |
|
|
2020
Q3 | $398K | Buy |
7,926
+120
| +2% | +$6.18K | 0.02% | 357 |
|
|
2020
Q2 | $398K | Buy |
7,806
+249
| +3% | +$12.1K | 0.03% | 353 |
|
|
2020
Q1 | $330K | Buy |
7,557
+1,472
| +24% | +$70.4K | 0.03% | 331 |
|
|
2019
Q4 | $305K | Sell |
6,085
-596
| -9% | -$27.9K | 0.02% | 398 |
|
|
2019
Q3 | $310K | Buy |
6,681
+2,235
| +50% | +$96.4K | 0.03% | 371 |
|
|
2019
Q2 | $192K | Buy |
4,446
+1,044
| +31% | +$44.4K | 0.02% | 455 |
|
|
2019
Q1 | $151K | Buy |
3,402
+1,642
| +93% | +$70.3K | 0.02% | 493 |
|
|
2018
Q4 | $76K | Buy |
1,760
+572
| +48% | +$25.2K | 0.01% | 620 |
|
|
2018
Q3 | $53K | Buy |
1,188
+257
| +28% | +$11K | 0.01% | 797 |
|
|
2018
Q2 | $37K | Sell |
931
-280
| -23% | -$11K | 0.01% | 838 |
|
|
2018
Q1 | $49K | Sell |
1,211
-807
| -40% | -$33.6K | 0.01% | 708 |
|
|
2017
Q4 | $87K | Sell |
2,018
-1,301
| -39% | -$60K | 0.01% | 532 |
|
|
2017
Q3 | $148K | Buy |
3,319
+385
| +13% | +$18.6K | 0.03% | 385 |
|
|
2017
Q2 | $139K | Buy |
2,934
+875
| +42% | +$41.8K | 0.03% | 390 |
|
|
2017
Q1 | $98K | Sell |
2,059
-118
| -5% | -$5.01K | 0.02% | 448 |
|
|
2016
Q4 | $88K | Buy |
+2,177
| New | +$85.8K | 0.02% | 419 |
|
Other funds holding SNY
MIP
Parallel Advisors's SNY Position: Q1 2026 in Review
Parallel Advisors increased its Sanofi (SNY) stake by 43% in Q1 2026, buying an estimated $90.6K and bringing the position to 6,503 shares worth $313K. The position accounts for 0.01% of the portfolio, ranked #926.
Parallel Advisors first reported a position in SNY in Q4 2016 and has held it in 38 quarters since. The position peaked at $533K in Q1 2025. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Parallel Advisors held 6,503 shares of Sanofi worth $313K as of Q1 2026.
- Parallel Advisors bought 1,944 Sanofi shares in Q1 2026, an estimated $90.6K.
- Sanofi made up 0.01% of Parallel Advisors's portfolio in Q1 2026, its #926 holding.
- Parallel Advisors first reported a position in Sanofi in Q4 2016 and has held it in 38 quarters since.
- Parallel Advisors's Sanofi position peaked at $533K in Q1 2025.
- 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.